Os05g0134200 Antibody

What is Os05g0134200 and what function does the antibody target?

Os05g0134200 refers to a specific gene locus in rice (Oryza sativa) encoding a protein involved in cellular signaling pathways. The antibody targeting this protein is designed for detection and analysis of the expressed protein product. Similar to other plant G-protein antibodies, it likely targets conserved epitopes that enable consistent detection across experimental conditions. The antibody recognizes specific amino acid sequences that serve as unique identifiers for the target protein, enabling researchers to track expression, localization, and interactions of this protein in various research contexts.

What experimental applications is Os05g0134200 Antibody suitable for?

Os05g0134200 Antibody has been validated for multiple research applications including:

The antibody demonstrates reliable performance across these applications with proper optimization and can be particularly valuable for studying protein-protein interactions involving Os05g0134200-encoded products.

How should Os05g0134200 Antibody be stored and handled to maintain efficacy?

For optimal preservation of antibody activity, Os05g0134200 Antibody should be stored according to these guidelines:

• Store lyophilized antibody at -20°C upon receipt

• After reconstitution, aliquot to minimize freeze-thaw cycles

• Use a manual defrost freezer rather than auto-defrost to prevent temperature fluctuations

• Avoid repeated freeze-thaw cycles as they can significantly reduce antibody activity

• Working dilutions should be prepared fresh and used within 24 hours

• For short-term storage (1-2 weeks), antibody can be kept at 4°C

Following these storage protocols will help maintain antibody specificity and signal strength across experiments, crucial for research reproducibility.

What species does Os05g0134200 Antibody cross-react with and how can cross-reactivity be verified?

Based on sequence homology analysis and experimental validation, Os05g0134200 Antibody demonstrates cross-reactivity with several plant species:

Researchers should verify cross-reactivity in their specific experimental system using positive and negative controls. For rigorous validation, consider using knockout/knockdown samples or peptide competition assays where the antibody is pre-incubated with excess target peptide before application to samples .

How can researchers troubleshoot non-specific binding when using Os05g0134200 Antibody?

Non-specific binding is a common challenge with plant antibodies. To troubleshoot:

• Optimize blocking conditions:

  • Test different blocking agents (BSA, milk, casein, commercial blockers)

  • Extend blocking time (2-4 hours at room temperature or overnight at 4°C)

  • Include 0.1-0.3% Triton X-100 in blocking buffer to reduce hydrophobic interactions

• Adjust antibody dilution:

  • Test a dilution series to identify optimal concentration

  • Consider extended incubation at lower concentrations (1:5000 overnight at 4°C)

• Modify washing protocols:

  • Increase wash duration and frequency

  • Add 0.05-0.1% Tween-20 to wash buffers

  • Consider high-salt wash buffers (up to 500mM NaCl) to disrupt low-affinity interactions

• Perform pre-adsorption:

  • Incubate antibody with tissue/cell lysate from species with high cross-reactivity

  • Remove bound antibodies by centrifugation before using in your experiment

These methodological refinements can significantly improve signal-to-noise ratio and experimental reproducibility.

What are the recommended protocols for using Os05g0134200 Antibody in co-immunoprecipitation studies?

For successful co-immunoprecipitation (Co-IP) experiments with Os05g0134200 Antibody:

• Sample preparation:

  • Use fresh tissue when possible

  • Extract proteins in non-denaturing buffer (e.g., 50mM Tris-HCl pH 7.5, 150mM NaCl, 0.5% NP-40, 1mM EDTA with protease inhibitors)

  • Clear lysate by centrifugation (14,000 × g, 10 minutes, 4°C)

• Antibody binding:

  • Pre-clear lysate with Protein A/G beads (1 hour, 4°C)

  • Incubate 1-5 μg antibody with 500 μg-1 mg protein lysate overnight at 4°C

  • Add 30-50 μl Protein A/G beads and incubate 2-4 hours at 4°C

• Washing and elution:

  • Wash beads 4-5 times with IP buffer containing reduced detergent (0.1% NP-40)

  • Elute proteins with 2X SDS sample buffer at 95°C for 5 minutes

• Controls:

  • Include IgG isotype control

  • Consider reverse Co-IP to confirm interaction

  • Include input sample (5-10% of lysate used for IP)

This protocol can be adapted based on the specific protein complex being studied and the experimental model system.

How can Os05g0134200 Antibody be validated for specificity in complex plant tissues?

Rigorous validation of antibody specificity in complex plant tissues requires multiple complementary approaches:

• Genetic validation:

  • Test antibody in wild-type versus knockout/knockdown plants

  • Validate using overexpression systems

  • Compare signal in tissues with known differential expression patterns

• Biochemical validation:

  • Perform peptide competition assays

  • Validate by mass spectrometry analysis of immunoprecipitated proteins

  • Test against recombinant proteins with site-directed mutations in key epitopes

• Orthogonal validation:

  • Compare protein detection with transcript levels via RT-qPCR

  • Use fluorescent protein fusions as independent markers

  • Employ multiple antibodies targeting different epitopes of the same protein

• Tissue-specific considerations:

  • Account for tissue-specific post-translational modifications

  • Consider fixation and processing effects on epitope accessibility

  • Validate across developmental stages

What techniques can be employed for using Os05g0134200 Antibody in cryoEM structural studies?

Utilizing Os05g0134200 Antibody in cryoEM studies requires careful planning:

• Sample preparation:

  • Purify target protein complex with gentle methods to preserve native structure

  • Consider using Fab fragments rather than whole IgG to reduce flexibility

  • Optimize antibody:protein ratios through gradient testing (typically 1:1 to 4:1)

• Grid preparation:

  • Test multiple grid types (Quantifoil, C-flat, UltrAuFoil)

  • Optimize blotting conditions (time, force, humidity)

  • Consider glow discharge or plasma cleaning parameters

• Data collection strategy:

  • Collect tilt series to address preferred orientation issues

  • Implement beam-induced motion correction

  • Use appropriate defocus range for high-resolution data

• Data processing considerations:

  • Classify particles to separate different antibody binding states

  • Account for antibody flexibility in 3D reconstruction

  • Consider focused refinement on the protein-antibody interface

The cryoEM approach allows visualization of antibody-epitope interactions at near-atomic resolution, providing insights into recognition mechanisms and potential allosteric effects upon binding .

How does sequence variation in Os05g0134200 across species impact antibody binding efficiency and experimental design?

Sequence variation across species presents important considerations for cross-species applications:

• Epitope conservation analysis:

  • Perform multiple sequence alignments to identify conserved and variable regions

  • Focus on epitope regions predicted or confirmed through epitope mapping

  • Calculate percent identity and similarity scores for key regions

• Impact on binding kinetics:

  • Single amino acid substitutions can alter binding affinity by orders of magnitude

  • Conservative substitutions (similar amino acid properties) generally have less impact

  • Post-translational modifications may create or mask epitopes

• Experimental design considerations:

  • Adjust antibody concentration based on predicted cross-reactivity

  • Extend incubation times for species with lower sequence homology

  • Consider developing species-specific detection methods for divergent species

• Validation approaches:

  • Perform side-by-side comparison with species-matched positive controls

  • Use recombinant proteins to quantify relative binding efficiencies

  • Consider developing calibration curves for quantitative applications

Understanding these sequence-dependent effects is crucial for experimental design across different plant species and for interpreting comparative data accurately.

What strategies can resolve inconsistent results when using Os05g0134200 Antibody across different research groups?

Addressing inconsistency in antibody performance requires systematic investigation:

• Source of variation analysis:

  • Antibody lot variation (request Certificate of Analysis for each lot)

  • Sample preparation differences (fixation methods, buffer compositions)

  • Detection system variations (secondary antibodies, visualization methods)

  • Technical expertise and protocol interpretation differences

• Standardization approaches:

  • Develop detailed standard operating procedures (SOPs)

  • Share positive control samples between laboratories

  • Implement quantitative quality control metrics

  • Consider antibody validation repositories for community-wide standards

• Experimental design improvements:

  • Include appropriate technical and biological replicates

  • Implement blinded analysis when possible

  • Document all relevant experimental parameters

  • Consider round-robin testing between collaborating labs

Consistent results across research groups typically require more detailed protocols than those provided in publications or product documentation, highlighting the importance of thorough methodology reporting.

How can researchers enhance signal-to-noise ratio when using Os05g0134200 Antibody in challenging samples?

For challenging samples such as high-background tissues or low-abundance targets:

• Sample preparation optimization:

  • Test different fixation protocols (duration, temperature, fixative composition)

  • Implement antigen retrieval methods when appropriate

  • Consider tissue clearing techniques for thick sections

  • Remove interfering compounds through additional purification steps

• Signal amplification strategies:

  • Tyramide signal amplification (TSA) for immunohistochemistry

  • Poly-HRP detection systems

  • Biotin-streptavidin amplification

  • Consider proximity ligation assay (PLA) for detecting protein-protein interactions

• Background reduction approaches:

  • Extended blocking (8-24 hours) with multiple blocking agents

  • Pre-adsorption of antibody with related proteins

  • Gradient centrifugation to remove autofluorescent components

  • Spectral unmixing for autofluorescent samples

• Advanced imaging techniques:

  • Implement deconvolution algorithms

  • Use confocal microscopy with narrow bandpass filters

  • Consider TIRF microscopy for membrane proteins

  • Employ structured illumination for improved resolution

These methodological refinements can dramatically improve detection of low-abundance Os05g0134200 protein even in challenging experimental systems.

How can Os05g0134200 Antibody be integrated into high-throughput screening workflows?

Adapting Os05g0134200 Antibody for high-throughput applications:

• Assay miniaturization:

  • Adapt to 384 or 1536-well formats

  • Optimize antibody concentration for reduced volumes

  • Implement automated liquid handling systems

  • Develop quality control metrics suitable for high-throughput screening

• Signal detection optimization:

  • Select high-sensitivity detection methods (TR-FRET, AlphaScreen)

  • Optimize signal development timing

  • Consider direct antibody labeling to reduce assay steps

  • Implement internal controls for normalization

• Data analysis approaches:

  • Develop automated image analysis pipelines

  • Implement machine learning for pattern recognition

  • Establish statistical thresholds for hit identification

  • Consider multiparametric analysis for complex phenotypes

• Validation strategies:

  • Develop orthogonal secondary assays

  • Implement dose-response confirmations

  • Establish counter-screens for false positives

  • Consider pathway-based validation approaches

High-throughput applications require extensive initial optimization but can dramatically accelerate discovery once established.

What considerations are important when using Os05g0134200 Antibody in multiplexed detection systems?

For multiplexed detection with Os05g0134200 Antibody alongside other antibodies:

• Compatibility assessment:

  • Test for cross-reactivity between antibodies

  • Evaluate buffer compatibility across antibody pairs

  • Consider epitope accessibility in multiplexed staining

  • Assess potential steric hindrance between closely-binding antibodies

• Technical optimization:

  • Implement sequential staining protocols when necessary

  • Consider tyramide-based sequential multiplexing

  • Test antibody cocktails at various concentrations

  • Optimize incubation times for balanced signal intensities

• Detection system design:

  • Select fluorophores with minimal spectral overlap

  • Consider quantum dots for narrow emission spectra

  • Implement spectral unmixing algorithms

  • Use metal-conjugated antibodies for mass cytometry applications

• Analytical considerations:

  • Develop compensation matrices for fluorescence spillover

  • Implement colocalization analysis workflows

  • Consider dimensionality reduction techniques for complex datasets

  • Validate using single-stain controls

Multiplexed detection enables powerful co-expression and interaction studies but requires careful optimization to ensure signal specificity and accurate data interpretation.